1. LIN28B Impairs the Transition of hESC-Derived β Cells from the Juvenile to Adult State.
- Author
-
Zhou X, Nair GG, Russ HA, Belair CD, Li ML, Shveygert M, Hebrok M, and Blelloch R
- Subjects
- Animals, Humans, Mice, MicroRNAs genetics, RNA Interference, RNA-Binding Proteins metabolism, Cell Differentiation genetics, Gene Expression Regulation, Developmental, Human Embryonic Stem Cells cytology, Human Embryonic Stem Cells metabolism, Insulin-Secreting Cells cytology, Insulin-Secreting Cells metabolism, RNA-Binding Proteins genetics
- Abstract
Differentiation of human embryonic stem cells into pancreatic β cells holds great promise for the treatment of diabetes. Recent advances have led to the production of glucose-responsive insulin-secreting cells in vitro, but resulting cells remain less mature than their adult primary β cell counterparts. The barrier(s) to in vitro β cell maturation are unclear. Here, we evaluated a potential role for microRNAs. MicroRNA profiling showed high expression of let-7 family microRNAs in vivo, but not in in vitro differentiated β cells. Reduced levels of let-7 in vitro were associated with increased levels of the RNA binding protein LIN28B, a negative regulator of let-7 biogenesis. Ablation of LIN28B during human embryonic stem cell (hESC) differentiation toward β cells led to a more mature glucose-stimulated insulin secretion profile and the suppression of juvenile-specific genes. However, let-7 overexpression had little effect. These results uncover LIN28B as a modulator of β cell maturation in vitro., (Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF